These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 24510061)
1. Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Scarpioni R; Rigante D; Cantarini L; Ricardi M; Albertazzi V; Melfa L; Lazzaro A Clin Rheumatol; 2015 Jul; 34(7):1311-6. PubMed ID: 24510061 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation. Itamiya T; Komai T; Kanda H; Nagafuchi Y; Chang H; Shibata S; Ishiura H; Shoda H; Toda T; Fujio K Clin Rheumatol; 2022 Jul; 41(7):2233-2237. PubMed ID: 35314925 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment. Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens. Kuemmerle-Deschner JB; Wittkowski H; Tyrrell PN; Koetter I; Lohse P; Ummenhofer K; Reess F; Hansmann S; Koitschev A; Deuter C; Bialkowski A; Foell D; Benseler SM Arthritis Res Ther; 2013; 15(3):R64. PubMed ID: 23718630 [TBL] [Abstract][Full Text] [Related]
15. Periodic fever: From Still's disease to Muckle-Wells syndrome. Solís Marquínez MN; García Fernández E; Morís de la Tassa J Reumatol Clin (Engl Ed); 2019; 15(5):e39-e40. PubMed ID: 28583784 [TBL] [Abstract][Full Text] [Related]
16. Adult patient diagnosed with Muckle-Wells syndrome, antiphospholipid syndrome and glomerular haematuria. Blokland SL; Limper M; van Eerde AM; Remmelts HH BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38191227 [TBL] [Abstract][Full Text] [Related]
17. Muckle-Wells syndrome: clinical perspectives. Tran TA Open Access Rheumatol; 2017; 9():123-129. PubMed ID: 28744167 [TBL] [Abstract][Full Text] [Related]
18. Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease. Fingerhutová Š; Fráňová J; Hlaváčková E; Jančová E; Procházková L; Beránková K; Tesařová M; Honsová E; Doležalová P Front Immunol; 2019; 10():802. PubMed ID: 31057541 [No Abstract] [Full Text] [Related]
19. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome. Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience. Russo RA; Melo-Gomes S; Lachmann HJ; Wynne K; Rajput K; Eleftheriou D; Edelsten C; Hawkins PN; Brogan PA Rheumatology (Oxford); 2014 Apr; 53(4):665-70. PubMed ID: 24352339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]